Innate Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Innate Pharma and buy or sell other stocks, ETFs, and their options commission-free!

About IPHA

Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62. 

CEO
Jonathan Dickinson
CEOJonathan Dickinson
Employees
181
Employees181
Headquarters
Marseille, Provence-Alpes-Cote-dAzur
HeadquartersMarseille, Provence-Alpes-Cote-dAzur
Founded
1999
Founded1999
Employees
181
Employees181

IPHA Key Statistics

Market cap
150.90M
Market cap150.90M
Price-Earnings ratio
-2.68
Price-Earnings ratio-2.68
Dividend yield
—
Dividend yield—
Average volume
6.27K
Average volume6.27K
High today
$1.58
High today$1.58
Low today
$1.58
Low today$1.58
Open price
$1.58
Open price$1.58
Volume
5.02K
Volume5.02K
52 Week high
$2.63
52 Week high$2.63
52 Week low
$1.57
52 Week low$1.57

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.